Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03648476 · ClinicalTrials.gov registry record · NA
Intervention to Change Attributions That Are Negative (ICAN)
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03648476 is a NA study that has completed, run by Indiana University. The registered enrollment target is 28 participants.
The verdict
NCT03648476, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
ICAN is the first treatment to target hostile attributions after TBI, making it a novel anger/ aggression management approach in this population. This is a randomized waitlist control trial. The length of time in the trial is approximately 15 weeks and the intervention is 6 weeks long.
Interventions
- BEHAVIORAL ICAN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2018-11-02 |
| Est. Completion | 2021-01-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03648476
The ClinicalTrials.gov registry entry for NCT03648476 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ICAN is the first listed.
NCT03648476 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03648476 about?
NCT03648476 is a clinical study titled "Intervention to Change Attributions That Are Negative (ICAN)". ICAN is the first treatment to target hostile attributions after TBI, making it a novel anger/ aggression management approach in this population. This is a randomized waitlist control trial. The length of time in the trial is approximately 15 weeks and the intervention is 6 weeks long.
What is the current status of trial NCT03648476?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2018-11-02. Estimated completion is 2021-01-11.
What interventions are being tested in trial NCT03648476?
The interventions under investigation include: ICAN (BEHAVIORAL).
Who is sponsoring clinical trial NCT03648476?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.